Prescription Digital Therapeutics: Reimagining Care in Behavior-Driven ConditionsAugust 15th 2022
Three experts discuss the impact of digital therapeutics (DTx) and prescription digital therapeutics (PDTs) as behavioral health therapy, from benefits to the treatment space to potential improvements and unmet needs.
Evaluating the Current and Future Opportunities for HIV PrEPDecember 23rd 2021
Discussion on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Examining Health Equity Among Different Racial and Ethnic Subpopulations With Multiple SclerosisMarch 26th 2021
Multiple sclerosis (MS) is a chronic disease that involves demyelination of plaque throughout the white and gray matter of the central nervous system. The early stages of MS are usually marked by a relapsing-remitting course of neurological deficits, which progress toward continuous, permanent dysfunction and disability. Of those with a diagnosis of MS, 74% are women.
Improving Ophthalmic Care Access and Treatment Among Aging AdultsMarch 22nd 2021
As the American population ages, chronic conditions are becoming an increasing challenge for payers. In addition to conditions such as cardiovascular disease and diabetes, eye disease is also prevalent among aging adults.